As a clinical biomarker of insulin resistance and type 2 diabetes [11], the quantitation of retinol binding protein 4 has gained much interest in the past few years and has been extensively studied and associated with a variety pathologies [25], [26], [27]. The gene discussed is RBP4; the disease is type 2 diabetes mellitus.